<code id='2284AF42A3'></code><style id='2284AF42A3'></style>
    • <acronym id='2284AF42A3'></acronym>
      <center id='2284AF42A3'><center id='2284AF42A3'><tfoot id='2284AF42A3'></tfoot></center><abbr id='2284AF42A3'><dir id='2284AF42A3'><tfoot id='2284AF42A3'></tfoot><noframes id='2284AF42A3'>

    • <optgroup id='2284AF42A3'><strike id='2284AF42A3'><sup id='2284AF42A3'></sup></strike><code id='2284AF42A3'></code></optgroup>
        1. <b id='2284AF42A3'><label id='2284AF42A3'><select id='2284AF42A3'><dt id='2284AF42A3'><span id='2284AF42A3'></span></dt></select></label></b><u id='2284AF42A3'></u>
          <i id='2284AF42A3'><strike id='2284AF42A3'><tt id='2284AF42A3'><pre id='2284AF42A3'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:fashion    Page View:997
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In